Investigational Site Number : 2500001

Saint-Herblain 44805

0 studies enrolling now · 3 studies all time

What they study most

Breast Cancer, Chronic Obstructive Pulmonary Disease, Non-small Cell Lung Cancer, Pleural Mesothelioma

Studies at this site

• Phase 1/2 Study of Amcenestrant (SAR439859) Single Agent and in Combination With Other Anti-cancer Therapies in Postmenopausal Women With Estrogen Receptor Positive Advanced Breast Cancer — Stopped early
• A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With Lung Cancer or Mesothelioma (Pegathor Lung 202) — Stopped early
• Pivotal Study to Assess the Efficacy, Safety and Tolerability of Dupilumab in Patients With Moderate to Severe COPD With Type 2 Inflammation — Completed